DarioHealth (DRIO) Cost of Revenue (2014 - 2026)

DarioHealth's Cost of Revenue history runs 13 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• Quarterly Cost of Revenue fell 16.93% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (down 30.86% YoY) and the FY2025 annual result came in at $9.7 million, down 29.62% from the prior year.
• Cost of Revenue was $2.4 million for Q1 2026 at DarioHealth, down from $2.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $5.0 million in Q2 2022 and bottomed at $2.0 million in Q3 2025.
• A 5-year average of $3.4 million and a median of $3.5 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 104.93% — and 2025, when it slumped 43.82%.
• DarioHealth's Cost of Revenue stood at $4.1 million in 2022, then retreated by 14.55% to $3.5 million in 2023, then decreased by 2.35% to $3.4 million in 2024, then retreated by 28.66% to $2.4 million in 2025, then retreated by 1.77% to $2.4 million in 2026.
• Business Quant data shows DRIO's Cost of Revenue at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.0 million in Q3 2025.